What is the purpose of this trial?

The EVOLVE Short DAPT Study is a prospective, multicenter, single-arm study designed to assess the safety of 3-month DAPT in subjects at high risk for bleeding undergoing PCI with a SYNERGY Stent System.

Participation Guidelines

Ages: 18 years and older

Gender: Both

Boston Scientific Corporation

Dates: 08/10/2016 - 04/30/2019

Last Updated: 02/22/2018

Study HIC#: 1603017502

Get Involved

For more information about this study, contact:
Nancy J. Hinchion
+1 203-453-7056

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image